TY  - JOUR

T1  - The STAR trial protocol: a randomised multi-stage phase II/III study of Sunitinib comparing temporary cessation with allowing continuation, at the time of maximal radiological response, in the first-line treatment of locally advanced/metastatic Renal Cancer

JO  - BMC CANCER

UR  - https://eprints.whiterose.ac.uk/107775/

PY  - 2012/12/14

AU  - Collinson FJ

AU  - Gregory WM

AU  - McCabe C

AU  - Howard H

AU  - Lowe C

AU  - Potrata D

AU  - Tubeuf S

AU  - Hanlon P

AU  - McParland L

AU  - Wah T

AU  - Selby PJ et al

ED  - 

DO  - DOI: 10.1186/1471-2407-12-598

VL  - 12

Y2  - 2024/12/22

ER  -